The Cell Line Development Market in North America is witnessing steady growth as pharmaceutical and biotechnology companies increasingly utilize mammalian and other cell-based systems for the development and manufacturing of biologics.
Market Overview
The cell line development market was valued at US$ 6.86 billion in 2023 and is expected to reach US$ 18.62 billion by 2031. The market is...